Clinical Trials Browser

Advanced Solid Tumor

Lymphoma, Large B-Cell, Diffuse

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Serous Ovarian Cancer

Breast Cancer Metastatic

Ovarian Neoplasms

Neoplasm Metastasis, Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma

Biliary Tract Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Stomach Neoplasms

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Pancreatic Cancer Non-resectable

Advanced Biliary Cancer

Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Squamous Non-small-cell Lung Cancer

Nasopharyngeal Carcinoma

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Solid Tumors

Pancreatic Neoplasms

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular, Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Lung Neoplasms

Adenocarcinoma

Clinical Trials

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma

RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer

PANTAX-Ib

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial

LIPUSU

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)

Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients

A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment

Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.

Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC